GENE ONLINE|News &
Opinion
Blog

Nasal Spray
Licensing FDA ApprovalAnaphylaxis
The First-Ever Nasal Spray for Anaphylactic Shock Gets FDA Approval
2024-08-12
Asia-Pacific AnxietyPhase 3 Trial
Vistagen’s Positive Phase 3 Results for Social Anxiety Treatment
2023-08-10
Trials & Approvals Overdose
Emergent BioSolutions’ Over-The-Counter Naloxone Nasal Spray Receives FDA Greenlight
2023-03-30
Trials & Approvals Migraine
Pfizer’s Fast-Acting Migraine Nasal Spray Takes Home US Approval
2023-03-13
Technology FDA
First Nasal Spray for Allergies Now Available Over-the-Counter
2022-07-13
Funding COVID-19
Google-Backed Leyden Labs Closes $140 Million Series B to Fight Viruses with Nasal Spray
2022-01-26
Trials & Approvals Nasal Spray
Oyster Point’s Nasal Spray for Dry Eyes Notches FDA Approval
2021-10-19
Trials & Approvals Depression
VistaGen’s Antidepressant Nasal Spray Succeeds Phase 2a Trial
2020-02-22
LATEST
Crossing Borders for a New Era in Medical Service Standards: Highlights from the 1st Asia Pacific Forum on Healthcare Quality
2024-12-12
Precision Medicine in Breast & Lung Cancer: Coordinated Diagnostics and Treatment Approaches for Personalized Care
2024-12-12
Fighting the Good Fight: Global Experts Unite to Share Oncology Breakthroughs at Asia-Pacific Precision Cancer Treatment Forum
2024-12-12
AI-Powered Blood Test Achieves 98% Accuracy in Early Breast Cancer Detection
2024-12-11
Taiwan’s Vice President Hsiao Bi-Khim Advocates Innovations in Medtech, Biotech, and Healthtech
2024-12-11
Six Game-Changing Cancer Treatments Built for Unstoppable Growth in 2025 – Part II
2024-12-11
Six Game-Changing Cancer Treatments Built for Unstoppable Growth in 2025 – Part I
2024-12-11
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top